
Royalty hostile bid for Elan in doubt after vote
DUBLIN (Reuters) - Elan shareholders approved a share buyback on Monday, meaning U.S.-based Royalty Pharma's hostile bid for the Irish drug firm will lapse unless it succeeds in a legal...
eNewspaper
Trending:









